You are here

Bone Marrow Microenvironment Could Offer Future Target in CML

December 31, 2013 | Chronic Myeloid Leukemia, Hematologic Malignancies, Leukemia & Lymphoma By Dave Levitan A small, hypolobated megakaryocyte in a bone marrow aspirate, typical ...

..
Modulation of the bone marrow microenvironment with parathyroid hormone (PTH) may be a feasible way to dramatically reduce counts of leukemia stem cells in chronic myeloid leukemia (CML) patients, according to new research in mice. Reducing leukemia stem cells (LSCs) is a required step on the path to a true cure for the disease.

- See more at:www.cancernetwork.com/news/bone-marrow-microenvironment-could-offer-future-target-cml